Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study

Lance Turtle, Mathew Thorpe, Thomas M Drake, Maaike Swets, Carlo Palmieri, Clark D Russell, Antonia Ho, Stephen Aston, Daniel G Wootton, Alex Richter, Thushan I de Silva, Hayley E Hardwick, Gary Leeming, Andy Law, Peter JM Openshaw, Ewen M Harrison, ISARIC4C investigators, J Kenneth Baillie, Malcolm G Semple, Annemarie B Docherty
doi: https://doi.org/10.1101/2022.08.08.22278576

Article Information

doi 
https://doi.org/10.1101/2022.08.08.22278576
History 
  • August 11, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Lance Turtle1,2,*,§,
  2. Mathew Thorpe3,*,
  3. Thomas M Drake3,
  4. Maaike Swets4,
  5. Carlo Palmieri5,
  6. Clark D Russell6,
  7. Antonia Ho7,
  8. Stephen Aston2,8,
  9. Daniel G Wootton1,2,
  10. Alex Richter9,10,
  11. Thushan I de Silva11,
  12. Hayley E Hardwick1,
  13. Gary Leeming12,
  14. Andy Law13,
  15. Peter JM Openshaw14,
  16. Ewen M Harrison3,
  17. ISARIC4C investigators,
  18. J Kenneth Baillie13,15,**,
  19. Malcolm G Semple1,16,** and
  20. Annemarie B Docherty3,15,**
  1. 1NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
  2. 2Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
  3. 3Centre for Medical Informatics, Usher Institute, University of Edinburgh, UK
  4. 4Department of Infectious Diseases, Leiden University Medical Centre, Leiden University, Leiden, the Netherlands
  5. 5Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK
  6. 6University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK
  7. 7MRC-University of Glasgow Centre for Virus Research, University of Glasgow, 464 Bearsden Road, Glasgow, UK
  8. 8Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool
  9. 9Institute of Cancer and Genomic Science, College of Medical and Dental Science, University of Birmingham, UK
  10. 10University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  11. 11Department of Infection, Immunity and Cardiovascular Disease, Medical School, The University of Sheffield, Sheffield, UK
  12. 12Department of Biostatistics, University of Liverpool, Liverpool, UK
  13. 13The Roslin Institute, Easter Bush campus, University of Edinburgh, Edinburgh, UK
  14. 14National Heart and Lung Institute, Imperial College London, London, UK
  15. 15Intensive Care Unit, Royal Infirmary Edinburgh, Edinburgh, UK
  16. 16Respiratory Medicine, Alder Hey Children’s Hospital, Liverpool, UK
  1. ↵§Corresponding author:
    Lance Turtle, Ronald Ross Building, Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, 8 West Derby Street, L69 7BE, Liverpool, UK. lance.turtle{at}liverpool.ac.uk

  1. ↵* Equal contribution

Back to top
Posted August 11, 2022.
Download PDF
Data/Code
Email
Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study
Lance Turtle, Mathew Thorpe, Thomas M Drake, Maaike Swets, Carlo Palmieri, Clark D Russell, Antonia Ho, Stephen Aston, Daniel G Wootton, Alex Richter, Thushan I de Silva, Hayley E Hardwick, Gary Leeming, Andy Law, Peter JM Openshaw, Ewen M Harrison, ISARIC4C investigators, J Kenneth Baillie, Malcolm G Semple, Annemarie B Docherty
medRxiv 2022.08.08.22278576; doi: https://doi.org/10.1101/2022.08.08.22278576
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area